NCT06814522View on ClinicalTrials.gov

Psilocybin-Assisted Therapy for Physician Well-Being and Burnout

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

July 31, 2026

Conditions
BurnoutBurnout, Healthcare Workers
Interventions
DRUG

Psilocybin, [3-[2-(dimethylamino)ethyl]-1H-indol-4-yl] dihydrogen phosphate

25 mg, single dose of synthetic psilocybin

All Listed Sponsors
lead

University of California, San Diego

OTHER

NCT06814522 - Psilocybin-Assisted Therapy for Physician Well-Being and Burnout | Biotech Hunter | Biotech Hunter